R20	Appositive Attribute:T331 Head:T286
R21	Appositive Attribute:T504 Head:T125
R22	Appositive Attribute:T504 Head:T128
R23	Appositive Attribute:T504 Head:T124
R24	Appositive Attribute:T504 Head:T126
R25	Appositive Attribute:T504 Head:T127
R26	Appositive Attribute:T520 Head:T156
R27	PredicateNominative Attribute:T496 Head:T301
R28	Anaphora Anaphor:T329 Antecedent:T328
R29	Anaphora Anaphor:T354 Antecedent:T214
R30	Anaphora Anaphor:T360 Antecedent:T217
R31	Anaphora Anaphor:T361 Antecedent:T360
R32	Anaphora Anaphor:T364 Antecedent:T366
T77	Drug_Class 9575 9607	other drugs affecting hemostasis
T80	Drug 9654 9661	aspirin
T81	Drug_Class 9663 9688	P2Y12 platelet inhibitors
T82	Drug_Class 9690 9717	other antithrombotic agents
T83	Drug_Class 9719 9739	fibrinolytic therapy
T84	Drug_Class 9745 9782	non-steroidal anti-inflammatory drugs
T85	Drug_Class 9858 9893	combined P-gp and CYP3A4 inhibitors
T86	Drug 9901 9913	ketoconazole
T87	Drug 9918 9927	ritonavir
T88	Drug 9939 9950	rivaroxaban
T91	Drug_Class 10072 10092	neuraxial anesthesia
T92	Drug_Class 10176 10196	anticoagulant agents
T94	Drug 12425 12432	XARELTO
T95	Drug_Class 12438 12480	combined P-gp and strong CYP3A4 inhibitors
T97	Drug 12488 12500	ketoconazole
T98	Drug 12502 12514	itraconazole
T99	Drug 12516 12535	lopinavir/ritonavir
T100	Drug 12537 12546	ritonavir
T101	Drug 12548 12567	indinavir/ritonavir
T102	Drug 12573 12583	conivaptan
T103	Drug_Class 12670 12710	combined P-gp and strong CYP3A4 inducers
T104	Drug 12718 12731	carbamazepine
T105	Drug 12733 12742	phenytoin
T106	Drug 12744 12752	rifampin
T107	Drug 12754 12757;12758 12769	St. John's wort
T108	Drug 12642 12649	XARELTO
T110	Drug_Class 13614 13677	Inhibitors and inducers of these CYP450 enzymes or transporters
T111	Drug 13685 13689	P-gp
T112	Drug 13716 13727	rivaroxaban
T114	Drug_Class 13897 13932	combined P-gp and CYP3A4 inhibitors
T116	Drug 14019 14030	rivaroxaban
T117	Drug_Class 15192 15232	combined P-gp and strong CYP3A4 inducers
T118	Drug 15240 15253	carbamazepine
T119	Drug 15255 15264	phenytoin
T120	Drug 15266 15274	rifampin
T121	Drug 15276 15279;15280 15291	St. John's wort
T124	Drug 13934 13946	ketoconazole
T125	Drug 13948 13957	ritonavir
T126	Drug 13959 13973	clarithromycin
T127	Drug 13975 13987	erythromycin
T128	Drug 13992 14003	fluconazole
T130	Drug_Class 13533 13612	CYP3A4/5, CYP2J2, and the P-gp and ATP-binding cassette G2 (ABCG2) transporters
T129	Drug 14553 14560	XARELTO
T132	Drug_Class 14566 14608	combined P-gp and strong CYP3A4 inhibitors
T134	Drug 14842 14849	XARELTO
T135	Drug_Class 14857 14896	combined P-gp and strong CYP3A4 inducer
T136	Drug 14904 14914	rifampicin
T137	Drug 14916 14925	phenytoin
T139	Drug 14937 14948	rivaroxaban
T141	Drug 15164 15171	XARELTO
T143	Drug 15387 15397	enoxaparin
T144	Drug 15402 15409	XARELTO
T146	Drug 15505 15513	warfarin
T147	Drug 15518 15525	XARELTO
T150	Drug 15601 15608	aspirin
T152	Drug_Class 15781 15787	NSAIDs
T153	Drug 15816 15823	XARELTO
T155	Drug_Class 15849 15879	platelet aggregation inhibitor
T156	Drug 15880 15891	clopidogrel
T157	Drug 15896 15903	XARELTO
T160	Drug 16024 16031	XARELTO
T161	Drug_Class 16043 16057	anticoagulants
T164	Drug 16217 16224	aspirin
T165	Drug_Class 16232 16263	platelet aggregation inhibitors
T166	Drug_Class 16268 16274	NSAIDs
T168	Drug 16475 16482	XARELTO
T169	Drug_Class 16523 16575	combined P-gp and weak or moderate CYP3A4 inhibitors
T170	Drug 16583 16593	amiodarone
T171	Drug 16595 16604	diltiazem
T172	Drug 16606 16615	verapamil
T173	Drug 16617 16626	quinidine
T174	Drug 16628 16638	ranolazine
T175	Drug 16640 16651	dronedarone
T176	Drug 16653 16663	felodipine
T177	Drug 16665 16677	erythromycin
T178	Drug 16683 16695	azithromycin
T180	Drug 16862 16869	XARELTO
T182	Drug_Class 16953 17005	combined P-gp and weak or moderate CYP3A4 inhibitors
T185	Drug_Class 14464 14514	drugs that are combined P-gp and CYP3A4 inhibitors
T186	Drug 2925 2953	low molecular weight heparin
T187	Drug_Class 12362 12386	Strong CYP3A4 Inhibitors
T188	Drug_Class 954 974	neuraxial anesthesia
T191	Drug_Class 9784 9790	NSAIDs
T192	Drug_Class 15355 15361	NSAIDs
T193	Drug_Class 15702 15708	NSAIDs
T194	Drug 0 7	XARELTO
T195	Drug 108 115	XARELTO
T196	Drug 300 307	XARELTO
T197	Drug 472 479	XARELTO
T198	Drug 584 591	XARELTO
T199	Drug 703 710	XARELTO
T200	Drug 928 935	XARELTO
T201	Drug 1409 1416	XARELTO
T202	Drug 1600 1607	XARELTO
T203	Drug 1668 1675	XARELTO
T204	Drug 1704 1711	XARELTO
T205	Drug 1755 1762	XARELTO
T206	Drug 1795 1802	XARELTO
T207	Drug 1932 1939	XARELTO
T208	Drug 2025 2032	XARELTO
T209	Drug 2046 2053	XARELTO
T210	Drug 2229 2236	XARELTO
T211	Drug 2321 2328	XARELTO
T212	Drug 2368 2375	XARELTO
T213	Drug 2446 2453	XARELTO
T214	Drug 2522 2529	XARELTO
T215	Drug 2628 2635	XARELTO
T216	Drug 2747 2754	XARELTO
T217	Drug 2834 2841	XARELTO
T218	Drug 3140 3147	XARELTO
T219	Drug 3286 3293	XARELTO
T220	Drug 3647 3654	XARELTO
T221	Drug 3832 3839	XARELTO
T222	Drug 3949 3956	XARELTO
T223	Drug 4232 4239	XARELTO
T224	Drug 4805 4812	XARELTO
T225	Drug 5027 5034	XARELTO
T226	Drug 5122 5129	XARELTO
T227	Drug 5497 5504	XARELTO
T228	Drug 5680 5687	XARELTO
T229	Drug 5726 5733	XARELTO
T230	Drug 6009 6016	XARELTO
T231	Drug 6133 6140	XARELTO
T232	Drug 6278 6285	XARELTO
T233	Drug 6569 6576	XARELTO
T234	Drug 6784 6791	XARELTO
T235	Drug 6927 6934	XARELTO
T236	Drug 7082 7089	XARELTO
T237	Drug 7277 7284	XARELTO
T238	Drug 7358 7365	XARELTO
T239	Drug 7510 7517	XARELTO
T240	Drug 7744 7751	XARELTO
T241	Drug 7917 7924	XARELTO
T242	Drug 7992 7999	XARELTO
T243	Drug 8240 8247	XARELTO
T244	Drug 8353 8360	XARELTO
T245	Drug 8594 8601	XARELTO
T246	Drug 10474 10481	XARELTO
T247	Drug 10492 10499	XARELTO
T248	Drug 10639 10646	XARELTO
T249	Drug 10772 10779	XARELTO
T250	Drug 11024 11031	XARELTO
T251	Drug 11085 11092	XARELTO
T252	Drug 11276 11283	XARELTO
T253	Drug 11562 11569	XARELTO
T254	Drug 11874 11881	XARELTO
T255	Drug 12092 12099	XARELTO
T256	Drug 12864 12871	XARELTO
T257	Drug 12971 12978	XARELTO
T258	Drug 13049 13056	XARELTO
T259	Drug 13345 13352	XARELTO
T260	Drug 13435 13442	XARELTO
T262	Drug 14391 14403	erythromycin
T264	Drug 15362 15369	Aspirin
T266	Drug 14375 14389	clarithromycin
T267	Drug 3061 3068	heparin
T268	Drug 1692 1700	Warfarin
T269	Drug 1743 1751	warfarin
T270	Drug 1776 1784	warfarin
T271	Drug 1943 1951	Warfarin
T272	Drug 2036 2044	warfarin
T273	Drug 2121 2129	warfarin
T274	Drug 2188 2196	warfarin
T275	Drug 2283 2291	warfarin
T276	Drug 2405 2413	Warfarin
T277	Drug 2735 2743	Warfarin
T279	Drug 2961 2969	warfarin
T280	Drug 7928 7936	warfarin
T281	Drug_Class 2379 2393	Anticoagulants
T282	Drug_Class 2709 2723	Anticoagulants
T284	Drug_Class 15336 15350	Anticoagulants
T285	Drug 9 20	rivaroxaban
T286	Drug 44 55	Rivaroxaban
T287	Drug 6695 6706	rivaroxaban
T288	Drug 7228 7239	rivaroxaban
T289	Drug 8689 8700	rivaroxaban
T290	Drug 8783 8794	rivaroxaban
T291	Drug 8853 8864	rivaroxaban
T292	Drug 9023 9034	rivaroxaban
T293	Drug 9150 9161	rivaroxaban
T294	Drug 9308 9319	rivaroxaban
T299	Drug 11348 11359	rivaroxaban
T300	Drug 11634 11645	rivaroxaban
T301	Drug 13503 13514	Rivaroxaban
T302	Drug 14208 14219	rivaroxaban
T303	Drug 15068 15079	rivaroxaban
T304	Drug 16823 16834	rivaroxaban
T305	Drug 12353 12357	P-gp
T307	Drug_Class 5349 5359	medication
T308	Drug 9255 9267	desmopressin
T309	Drug_Class 69 78	inhibitor
T311	Drug_Class 16785 16794	inhibitor
T3	Drug_Class 2475 2508	an anticoagulant with rapid onset
T12	Drug_Class 2790 2826	an anticoagulant other than warfarin
T59	Drug_Class 2252 2278	a parenteral anticoagulant
T63	Drug 9089 9104	tranexamic acid
T75	Drug 9106 9123	aminocaproic acid
T78	Drug 9272 9281	aprotinin
T328	ZeroArticleNP 22 28	tablet
T329	DefiniteNP 83 104	the active ingredient
T330	DefiniteNP 129 157	the chemical name 5-Chloro-N
T331	IndefiniteNP 57 78	a factor Xa inhibitor
T332	DefiniteNP 318 326	THE RISK
T333	IndefiniteNP 268 269	A
T334	DefiniteNP 490 498	THE RISK
T335	DefiniteNP 603 611	the risk
T336	IndefiniteNP 550 572	any oral anticoagulant
T337	IndefiniteNP 678 699	another anticoagulant
T338	IndefiniteNP 731 739	a reason
T339	IndefiniteNP 790 798	a course
T340	DemonstrativeNP 644 653	this risk
T341	ZeroArticleNP 802 809	therapy
T342	DemonstrativeNP 1006 1021	These hematomas
T343	DefiniteNP 1207 1219	the benefits
T344	DefiniteNP 1389 1424	The 15 mg and 20 mg XARELTO tablets
T345	DefiniteNP 1458 1474	the 10 mg tablet
T346	DefiniteNP 1549 1599	the nonvalvular atrial fibrillation efficacy study
T347	DefiniteNP 1623 1639	the evening meal
T348	DefiniteNP 1814 1848	the International Normalized Ratio
T349	DefiniteNP 2164 2184	the appropriate dose
T350	DefiniteNP 2295 2303	the time
T351	DefiniteNP 2304 2317	the next dose
T352	IndefiniteNP 2252 2278	a parenteral anticoagulant
T353	DefiniteNP 2539 2553	the first dose
T354	DefiniteNP 2557 2580	the other anticoagulant
T355	DefiniteNP 2605 2613	the time
T356	DefiniteNP 2619 2640	the next XARELTO dose
T357	IndefiniteNP 2475 2508	an anticoagulant with rapid onset
T358	ZeroArticleNP 2668 2685	Drug Interactions
T359	DefiniteNP 2864 2905	the next scheduled evening administration
T360	DefiniteNP 2909 2917	the drug
T361	DefiniteNP 3017 3040	the other anticoagulant
T362	IndefiniteNP 2790 2826	an anticoagulant other than warfarin
T363	ZeroArticleNP 2957 2988	non-warfarin oral anticoagulant
T364	DefiniteNP 3117 3129	the infusion
T365	DefiniteNP 3151 3164	the same time
T366	ZeroArticleNP 3091 3110	continuous infusion
T367	DefiniteNP 3262 3282	the recommended dose
T368	DefiniteNP 3332 3348	the evening meal
T369	DefiniteNP 3390 3410	the recommended dose
T370	DefiniteNP 3436 3452	the evening meal
T371	DefiniteNP 3582 3590	the Risk
T372	DefiniteNP 3623 3643	The recommended dose
T373	DefiniteNP 3659 3680	the initial treatment
T374	DefiniteNP 3752 3769	the first 21 days
T375	DefiniteNP 3808 3828	the recommended dose
T376	DefiniteNP 3901 3914	the same time
T377	DemonstrativeNP 3777 3806	this initial treatment period
T378	DistributiveNP 3915 3923	each day
T379	DefiniteNP 3925 3945	The recommended dose
T380	DefiniteNP 3974 3982	the risk
T381	DefiniteNP 4070 4083	the same time
T382	DistributiveNP 4084 4092	each day
T383	DefiniteNP 4208 4228	The recommended dose
T384	DefiniteNP 4295 4311	The initial dose
T385	DefiniteNP 4749 4757	the risk
T386	DefiniteNP 4856 4869	the procedure
T387	DefiniteNP 4880 4888	the risk
T388	DefiniteNP 5010 5023	the last dose
T389	DefiniteNP 5036 5054	the increased risk
T390	DefiniteNP 5093 5104	the urgency
T391	IndefiniteNP 4959 4970	a procedure
T392	DefiniteNP 5156 5188	the surgical or other procedures
T393	DefiniteNP 5254 5262	the time
T394	IndefiniteNP 5438 5464	a parenteral anticoagulant
T395	ZeroArticleNP 5344 5359	oral medication
T396	DefiniteNP 5521 5539	the scheduled time
T397	DefiniteNP 5552 5560	the dose
T398	DefiniteNP 5584 5596	the same day
T399	IndefiniteNP 5487 5493	a dose
T400	DefiniteNP 5656 5667	The patient
T401	DemonstrativeNP 5746 5770	this particular instance
T402	ZeroArticleNP 5776 5789	15 mg tablets
T403	DefiniteNP 5812 5823	The patient
T404	DefiniteNP 5845 5862	the regular 15 mg
T405	DefiniteNP 5900 5917	the following day
T406	DefiniteNP 5974 5985	The patient
T407	DefiniteNP 5998 6021	the missed XARELTO dose
T408	ZeroArticleNP 6103 6116	whole tablets
T409	ZeroArticleNP 6127 6148	20 mg XARELTO tablets
T410	DefiniteNP 6246 6264	the administration
T411	DefiniteNP 6309 6317	the dose
T412	IndefiniteNP 6268 6291	a crushed XARELTO 15 mg
T413	ZeroArticleNP 6298 6307	mg tablet
T414	DefiniteNP 6544 6552	the tube
T415	IndefiniteNP 6653 6663	an NG tube
T416	ZeroArticleNP 6563 6584	20 mg XARELTO tablets
T417	DefiniteNP 6734 6742	the site
T418	DefiniteNP 6802 6813	the stomach
T419	ZeroArticleNP 6746 6758	drug release
T420	ZeroArticleNP 6874 6887	drug exposure
T421	DefiniteNP 6895 6913	the administration
T422	DefiniteNP 6958 6966	the dose
T423	IndefiniteNP 6917 6940	a crushed XARELTO 15 mg
T424	ZeroArticleNP 6947 6956	mg tablet
T425	ZeroArticleNP 7076 7097	20 mg XARELTO tablets
T426	IndefiniteNP 7245 7263	a water suspension
T427	IndefiniteNP 7267 7291	a crushed XARELTO tablet
T428	DefiniteNP 7756 7767	the absence
T429	DefiniteNP 7818 7826	the risk
T430	IndefiniteNP 7710 7732	any oral anticoagulant
T431	DefiniteNP 7897 7911	the transition
T432	IndefiniteNP 7849 7866	An increased rate
T433	IndefiniteNP 8020 8028	a reason
T434	IndefiniteNP 8079 8087	a course
T435	IndefiniteNP 8123 8144	another anticoagulant
T436	ZeroArticleNP 8091 8098	therapy
T437	DefiniteNP 8258 8266	the risk
T438	DefiniteNP 8404 8412	the risk
T439	DefiniteNP 8460 8468	the risk
T440	DefiniteNP 8550 8558	the need
T441	IndefiniteNP 8501 8510	any signs
T442	DefiniteNP 8651 8685	The terminal elimination half-life
T443	IndefiniteNP 8759 8778	A specific antidote
T444	DefiniteNP 8993 9019	the anticoagulant activity
T445	ZeroArticleNP 9064 9087	antifibrinolytic agents
T446	DistributiveNP 9172 9200	neither scientific rationale
T447	ZeroArticleNP 9328 9356	procoagulant reversal agents
T448	DefiniteNP 9618 9626	the risk
T449	IndefiniteNP 9575 9607	other drugs affecting hemostasis
T450	IndefiniteNP 9690 9717	other antithrombotic agents
T451	ZeroArticleNP 9663 9688	P2Y12 platelet inhibitors
T452	ZeroArticleNP 9719 9739	fibrinolytic therapy
T453	ZeroArticleNP 9745 9782	non-steroidal anti-inflammatory drugs
T454	ZeroArticleNP 9797 9814	Drug Interactions
T455	ZeroArticleNP 9843 9848	drugs
T456	ZeroArticleNP 9858 9893	combined P-gp and CYP3A4 inhibitors
T457	ZeroArticleNP 9996 10013	Drug Interactions
T458	IndefiniteNP 10270 10300	an epidural or spinal hematoma
T459	ZeroArticleNP 10176 10196	anticoagulant agents
T460	DefiniteNP 10447 10470	the last administration
T461	IndefiniteNP 10376 10396	An epidural catheter
T462	DefiniteNP 10483 10504	The next XARELTO dose
T463	DefiniteNP 10558 10569	the removal
T464	DefiniteNP 10573 10585	the catheter
T465	DefiniteNP 10617 10635	the administration
T466	DefiniteNP 10761 10768	the use
T467	ZeroArticleNP 10819 10832	drug exposure
T468	ZeroArticleNP 10991 10998	therapy
T469	DefiniteNP 11218 11226	the Risk
T470	DefiniteNP 11265 11272	the use
T471	IndefiniteNP 11324 11344	an expected increase
T472	DemonstrativeNP 11400 11423	this patient population
T473	DefiniteNP 11551 11558	the use
T474	IndefiniteNP 11610 11630	an expected increase
T475	DemonstrativeNP 11686 11709	this patient population
T476	IndefiniteNP 11749 11758	any signs
T477	DefiniteNP 11901 11914	the treatment
T478	IndefiniteNP 12194 12213	any hepatic disease
T479	ZeroArticleNP 12249 12262	drug exposure
T480	ZeroArticleNP 12362 12386	Strong CYP3A4 Inhibitors
T481	ZeroArticleNP 12390 12398	Inducers
T482	ZeroArticleNP 12438 12480	combined P-gp and strong CYP3A4 inhibitors
T483	ZeroArticleNP 12590 12607	Drug Interactions
T484	ZeroArticleNP 12655 12660	drugs
T485	ZeroArticleNP 12670 12710	combined P-gp and strong CYP3A4 inducers
T486	ZeroArticleNP 12776 12793	Drug Interactions
T487	DefiniteNP 12895 12916	the potential benefit
T488	DefiniteNP 12927 12945	the potential risk
T489	DefiniteNP 12949 12959	the mother
T490	DefiniteNP 13021 13045	The anticoagulant effect
T491	IndefiniteNP 13150 13159	any signs
T492	IndefiniteNP 13201 13207	a drop
T493	DefiniteNP 13318 13328	The safety
T494	DemonstrativeNP 13465 13479	these patients
T495	ZeroArticleNP 13482 13488	7 DRUG
T496	IndefiniteNP 13518 13529	a substrate
T497	DemonstrativeNP 13614 13677	Inhibitors and inducers of these CYP450 enzymes or transporters
T498	ZeroArticleNP 13739 13748	7.1 Drugs
T499	ZeroArticleNP 13762 13789	Cytochrome P450 3A4 Enzymes
T500	ZeroArticleNP 13794 13798	Drug
T501	DefiniteNP 13857 13876	the concomitant use
T502	ZeroArticleNP 13821 13845	drug interaction studies
T503	ZeroArticleNP 13882 13887	drugs
T504	ZeroArticleNP 13897 13932	combined P-gp and CYP3A4 inhibitors
T505	DefiniteNP 14132 14145	The increases
T506	IndefiniteNP 14311 14319	a change
T507	ZeroArticleNP 14464 14514	drugs that are combined P-gp and CYP3A4 inhibitors
T508	ZeroArticleNP 14566 14608	combined P-gp and strong CYP3A4 inhibitors
T509	ZeroArticleNP 14648 14657	7.2 Drugs
T510	ZeroArticleNP 14670 14697	Cytochrome P450 3A4 Enzymes
T511	ZeroArticleNP 14702 14706	Drug
T512	IndefiniteNP 14855 14896	a combined P-gp and strong CYP3A4 inducer
T513	ZeroArticleNP 14739 14763	drug interaction studies
T514	DemonstrativeNP 15037 15052	These decreases
T515	ZeroArticleNP 15177 15182	drugs
T516	ZeroArticleNP 15192 15232	combined P-gp and strong CYP3A4 inducers
T517	IndefiniteNP 15442 15460	an additive effect
T518	IndefiniteNP 15538 15556	an additive effect
T519	IndefiniteNP 15636 15662	an independent risk factor
T520	DefiniteNP 15845 15879	the platelet aggregation inhibitor
T521	IndefiniteNP 15916 15927	an increase
T522	IndefiniteNP 15949 15962	some subjects
T523	IndefiniteNP 16138 16147	any signs
T524	IndefiniteNP 16226 16263	other platelet aggregation inhibitors
T525	ZeroArticleNP 16349 16354	Drugs
T526	ZeroArticleNP 16368 16395	Cytochrome P450 3A4 Enzymes
T527	ZeroArticleNP 16400 16404	Drug
T528	DistributiveNP 16806 16819	both pathways
T529	ZeroArticleNP 16486 16497	combination
T530	ZeroArticleNP 16503 16508	drugs
T531	ZeroArticleNP 16523 16575	combined P-gp and weak or moderate CYP3A4 inhibitors
T532	DefiniteNP 17014 17035	the potential benefit
T533	DefiniteNP 17046 17064	the potential risk
T534	ZeroArticleNP 16941 17005	concomitant combined P-gp and weak or moderate CYP3A4 inhibitors
